Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP).

Helmut Salzer; et al.

doi:10.1055/a-2182-1609

Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP).

Division of Infectious Diseases and Tropical Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	35-46
Number of pages	12
Journal	Pneumologie
Volume	78
Issue number	1
DOIs	https://doi.org/10.1055/a-2182-1609
Publication status	Published - Oct 2023

Fields of science

303031 Tropical medicine
302030 Internal medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1055/a-2182-1609

Cite this

Salzer, H., & et al. (2023). Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP). Pneumologie, 78(1), 35-46. https://doi.org/10.1055/a-2182-1609

Salzer, Helmut ; et al. / Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP). In: Pneumologie. 2023 ; Vol. 78, No. 1. pp. 35-46.

@article{5b527f7ffb0944149b558a6b6bf319ba,

title = "Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP).",

author = "Helmut Salzer and \{et al.\}",

year = "2023",

month = oct,

doi = "10.1055/a-2182-1609",

language = "English",

volume = "78",

pages = "35--46",

journal = "Pneumologie",

number = "1",

}

Salzer, H & et al. 2023, 'Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP).', Pneumologie, vol. 78, no. 1, pp. 35-46. https://doi.org/10.1055/a-2182-1609

Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP). / Salzer, Helmut; et al.
In: Pneumologie, Vol. 78, No. 1, 10.2023, p. 35-46.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP).

AU - Salzer, Helmut

AU - et al., null

PY - 2023/10

Y1 - 2023/10

UR - http://www.scopus.com/inward/record.url?scp=85182727041&partnerID=8YFLogxK

U2 - 10.1055/a-2182-1609

DO - 10.1055/a-2182-1609

M3 - Article

VL - 78

SP - 35

EP - 46

JO - Pneumologie

JF - Pneumologie

IS - 1

ER -

Salzer H, et al. Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP). Pneumologie. 2023 Oct;78(1):35-46. doi: 10.1055/a-2182-1609

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this